Elevated free fatty acid is associated with cardioembolic stroke subtype

Canadian Journal of Neurological Sciences

Volumn 38, Issue 6, 2011, Pages 874-879

  Seo, Woo Keun ^a   Kim, Juyeon ^a   Kim, Yoo ^a   Kim, Ji ^a   Oh, Kyungmi ^a   Koh, Seong Beom ^a   Seo, Hong ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBRAL ARTERY DISEASE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; STROKE;

EID: 80155177841     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100012464     Document Type: Article

References (32)

1. Pilz S, MarzW. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med. 2008;46:429-34. (Pubitemid 351820374)
2. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463-78. (Pubitemid 38269844)
3. Oram JF, Bornfeldt KE. Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes. Front Biosci. 2004;9:1240-53. (Pubitemid 39060840)
4. Opie LH. The metabolic vicious cycle in heart failure. Lancet. 2004;364:1733-4. (Pubitemid 39488043)
5. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155-8.
6. Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens. 2009;22:151-5.
7. Oliver MF. Sudden cardiac death: the lost fatty acid hypothesis. QJM. 2006;99:701-9. (Pubitemid 44542319)
8. Kurien VA, Oliver MF. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet. 1970;1:813-15.
9. Taniguchi A, Nakai Y, Fukushima M, et al. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids. Metabolism. 2002;51: 539-43. (Pubitemid 34516504)
10. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke: co-sponsored by the council on cardiovascular radiology and intervention: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37: 577-617. (Pubitemid 43732031)
11. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285: 2370-5. (Pubitemid 32424106)
12. Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
13. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58:688-97. (Pubitemid 41552544)
14. Cocco G, Chu D. Rimonabant may induce atrial fibrillation. BMJ. 2009;338:b1061.
15. Leite CE, Mocelin CA, Petersen GO, Leal MB, Thiesen FV. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep. 2009;61:217-24.
16. Despres JP, Golay A, Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005;353:2121-34. (Pubitemid 41653104)
17. Tansey MJ, Opie LH. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet. 1983;2:419-22. (Pubitemid 13043449)
18. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation. 2001;104:756-61. (Pubitemid 32762671)
19. Paolisso G, Gualdiero P, Manzella D, et al. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Am J Cardiol. 1997;80:932-7. (Pubitemid 27459171)
20. Pilz S, Scharnagl H, Tiran B, et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab. 2006;91:2542-7. (Pubitemid 44024615)
21. Pilz S, Scharnagl H, Tiran B, et al. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J. 2007;28: 2763-9. (Pubitemid 350135527)
22. Hillered L, Chan PH. Effects of arachidonic acid on respiratory activities in isolated brain mitochondria. J Neurosci Res. 1988; 19:94-100. (Pubitemid 18040552)
23. Hillered L, Chan PH. Role of arachidonic acid and other free fatty acids in mitochondrial dysfunction in brain ischemia. J Neurosci Res. 1988;20:451-6.
24. Clark WM,Wechsler LR, Sabounjian LA, Schwiderski UE.Aphase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology. 2001;57:1595-602. (Pubitemid 33055476)
25. Paik MJ, Li WY, Ahn YH, et al. The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clin Chim Acta. 2009;402:25-30.
26. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67. (Pubitemid 351650486)
27. Romano JG, Sacco RL. Progress in secondary stroke prevention. Ann Neurol. 2008;63:418-27. (Pubitemid 351637501)
28. Bajpai A, Savelieva I, Camm AJ. Treatment of atrial fibrillation. Br Med Bull. 2008;88:75-94.
29. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;375:1212-23.
30. Richieri GV, Kleinfeld AM. Unbound free fatty acid levels in human serum. J Lipid Res. 1995;36:229-40.
31. Huang T, Tucker KL, Lee YC, et al. Methylenetetrahydrofolate reductase variants that associated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in Puerto Rican adults. J Nutr. 2011;141:654-9.
32. Riemersma RA, Logan R, Russell DC, Smith HS, Simpson J, Oliver MF. Effect of heparin on plasma free fatty acid concentrations after acute myocardial infarction. Br Heart J. 1982;48:134-9. (Pubitemid 12093597)